Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-731P (RNA, U6 small nuclear 731, pseudogene) is classified as a pseudogene of the U6 small nuclear RNA gene family in humans[1][3]. Pseudogenes like RNU6-731P are genomic DNA sequences similar to normal genes but are typically nonfunctional due to disruptive mutations or lack of regulatory elements required for gene expression[2]. While some pseudogenes can regulate parent gene expression or participate in RNA-based regulatory networks, most—including RNU6-731P—are presumed unexpressed and are not associated with protein-coding function, drug targeting, or established disease roles[1][3][4]. There is no evidence linking this pseudogene to therapeutic targeting, drug interaction, or use as a biomarker. The entry may be considered incorrect or irrelevant in therapeutic targeting contexts because pseudogenes, by definition, are not druggable targets, enzymes, transporters, or receptors[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 731, pseudogene (RNU6-731P).